Competitive Technologies, Inc. Stock NYSE

CTT

US2045121074

Advanced Medical Equipment & Technology

OTC Markets Traded

End-of-day quote NYSE
- ^USD	-

20-06-09	Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	CI
19-07-19	Calmare Therapeutics Incorporated Announces Board Changes	CI

Latest news: Competitive Technologies, Inc.

20-06-09	Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	CI
19-07-19	Calmare Therapeutics Incorporated Announces Board Changes	CI
19-06-12	Carl O'connell to Resign as Member of the Board of Directors of Calmare Therapeutics Incorporation, Effective on or About June 26, 2019	CI
18-07-02	Declaration of Voting Results by Calmare Therapeutics	CI
18-06-15	Calmare Therapeutics Declares Preliminary Tally of Consents by Shareholders	CI
18-01-16	Calmare Therapeutics Solicits Proxies from Shareholders	CI
18-01-12	Calmare Therapeutics Solicits Proxies from Shareholders	CI
18-01-02	Calmare Therapeutics Solicits Proxies from Shareholders	CI
17-12-08	Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	CI
17-12-04	Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	CI
17-11-22	Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	CI
17-09-21	Stanley Yarbro Sends Letter to Board of Directors of Calmare Therapeutics	CI
17-09-21	Stanley Yarbro Sends Director Nomination Notice to Calmare Therapeutics	CI

More news

Press Releases: Competitive Technologies, Inc.

20-06-09

CALMARE THERAPEUTICS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)

More press releases

Managers and Directors: Competitive Technologies, Inc.

Manager	Title	Age	Since
Conrad Mir CEO	Chief Executive Officer	57	2013-09-26
Thomas Richtarich DFI	Director of Finance/CFO	73	-
Donna Mays ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Rustin Howard CHM	Chairman	69	2011-12-15
Peter Brennan CHM	Chairman	71	2012-05-31
Stanley Yarbro BRD	Director/Board Member	76	-

More insiders

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	-0.41%	-2.66%	+17.44%	+45.43%	250B
DANAHER CORPORATION	+0.30%	+0.11%	+2.94%	+12.37%	162B
INTUITIVE SURGICAL, INC.	+2.13%	+6.04%	-17.93%	+65.99%	154B
BOSTON SCIENTIFIC CORPORATION	-0.80%	+2.78%	-55.44%	-8.99%	66.68B
SIEMENS HEALTHINEERS AG	+0.24%	+0.99%	-15.19%	-10.88%	52.08B
VEEVA SYSTEMS INC.	+0.53%	+4.04%	+10.78%	+65.48%	52.22B
EDWARDS LIFESCIENCES CORPORATION	-1.12%	+3.03%	+16.58%	+29.21%	51.93B
AGILENT TECHNOLOGIES, INC.	+0.14%	-0.24%	+17.02%	+57.82%	49.02B
WATERS CORPORATION	-0.51%	+3.39%	+27.02%	+76.71%	44.76B
Average	-0.07%	+1.50%	+0.36%	+37.02%	98.04B
Weighted average by Cap.	+0.01%	+0.55%	+1.20%	+38.03%

See all sector performances

Calmare Therapeutics Incorporated is a biotherapeutic company. The Company's medical devices offer a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. It supplements its medical devices with a catalog of private label neurostimulation and sensory electrodes. Its flagship medical device, the Calmare Pain Therapy Device is a non-invasive and non-addictive modality that treats chronic and neuropathic pain. Its devices are commercially sold to medical practices throughout the world. Its technology portfolio includes PMT 1, Neuroprotection and Cognitive Enhancement, Sexual Dysfunction Therapeutic, Skin Pigment Enhancer and Wound Sealant. The Company's clients include universities, corporations, and inventors.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company